MedPath

常州恒邦药业有限公司

Ownership
-
Established
2018-04-02
Employees
-
Market Cap
-
Website

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

4

NMPA:4

Drug Approvals

Apixaban Tablets

Product Name
阿哌沙班片
Approval Number
国药准字H20193003
Approval Date
Sep 1, 2023
NMPA

Ambrisentan Tablets

Product Name
安立生坦片
Approval Number
国药准字H20183321
Approval Date
Mar 23, 2023
NMPA

Canagliflozin Tablets

Product Name
卡格列净片
Approval Number
国药准字H20193392
Approval Date
Dec 18, 2019
NMPA

Canagliflozin Tablets

Product Name
卡格列净片
Approval Number
国药准字H20193393
Approval Date
Dec 18, 2019
NMPA

Clinical Trials

No trials found

News

No news found
© Copyright 2025. All Rights Reserved by MedPath